共 50 条
- [31] Non-Adherence to Disease-Modifying Anti-Rheumatic Drugs in Patients with Rheumatoid Arthritis: An Italian SurveyARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1045 - S1046Bianchi, GerolamoCarletto, AntonioEpis, Oscar MassimilianoScioscia, CrescenzioSemeraro, AngeloBianchino, LauraBazzichi, LauraLapadula, GiovanniSinigaglia, LuigiLo Monaco, Andrea
- [32] The economic burden of switching targeted disease-modifying anti-rheumatic drugs among rheumatoid arthritis patientsJOURNAL OF MEDICAL ECONOMICS, 2019, 22 (04) : 350 - 358Shahabi, AhvaShafrin, JasonZhao, LaurenGreen, SarahCurtice, TammyMarshall, AlexanderPaul, Damemarie
- [33] IMMUNOGENICITY OF SUBCUTANEOUS AND INTRAVENOUS TOCILIZUMAB AS MONOTHERAPY OR IN COMBINATION WITH DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITISRHEUMATOLOGY, 2016, 55 : 92 - 93Genovese, Mark C.Ogata, AtsushiNomura, AkiraBao, MinHitraya, ElenaLacey, StuartBurmester, Gerd R.
- [34] A narrative review of the comparative safety of disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid arthritisEXPERT OPINION ON DRUG SAFETY, 2024, : 687 - 714Sen, RouhinRiofrio, MariaSingh, Jasvinder A.
- [35] Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugsScientific Reports, 10Ahmad Y. AbuhelwaAshley M. HopkinsMichael J. SorichSusanna ProudmanDavid J. R. FosterMichael D. Wiese
- [36] Biologic disease-modifying anti-rheumatic drugs and kinase inhibitors: differences in efficacy and safety in rheumatoid arthritisClinical Rheumatology, 2021, 40 : 4369 - 4372Roy Fleischmann
- [37] Response to traditional disease-modifying anti-rheumatic drugs in indigent South Africans with early rheumatoid arthritisCLINICAL RHEUMATOLOGY, 2012, 31 (04) : 613 - 619Hodkinson, B.Musenge, E.Ally, M.Meyer, P. W. A.Anderson, R.Tikly, M.
- [38] Prescribing patterns and clinical outcomes of biological disease-modifying anti-rheumatic drugs for rheumatoid arthritis in SpainEUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (15) : 8177 - 8184Martinez-Mugica, C.Manso, G.
- [39] Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugsSCIENTIFIC REPORTS, 2020, 10 (01)Abuhelwa, Ahmad Y.Hopkins, Ashley M.Sorich, Michael J.Proudman, SusannaFoster, David J. R.Wiese, Michael D.
- [40] Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic DrugsFRONTIERS IN IMMUNOLOGY, 2021, 12Arias de la Rosa, IvanEscudero-Contreras, AlejandroRuiz-Ponce, MiriamRoman-Rodriguez, CristobalPerez-Sanchez, CarlosAbalos-Aguilera, Maria del CarmenOrtega-Castro, RafaelaAlcaide, JuanMurri, MoraFont, PilarCalvo-Gutierrez, JerusalemLuque-Tevar, MariaPatino-Trives, Alejandra MariaGuzman-Ruiz, RocioMalagon, Maria del MarTinahones, Francisco JoseCollantes-Estevez, EduardoLopez-Pedrera, CharyBarbarroja, Nuria